Featured Research

from universities, journals, and other organizations

Transplant success tied to naturally high levels of powerful immune molecule package

Date:
April 28, 2014
Source:
Medical College of Georgia at Georgia Regents University
Summary:
Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report. Physicians already examine HLA, or human leukocyte antigen, when identifying the best organ donor. When a patient and donor have the same or similar antigens, which are markers for what the body identifies as self and foreign, it increases the chance of a successful transplant.

This is Dr. Laura L. Mulloy, Chief of the MCG Section of Nephrology, Hypertension and Transplantation Medicine and Dr. Anatolij Horuzsko, immunologist both at the Medical College of Georgia at Georgia Regents University.
Credit: Phil Jones

Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report.

A study of 67 transplant patients -- 50 with no evidence of rejection and 17 with chronic rejection -- showed those most tolerant of their kidney had naturally high levels of HLA-G dimer, where two of the immune molecules bind together, said Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University.

Knowing which form of HLA-G correlates with optimal transplant success could enable physicians to further tailor the delicate balance of prescribing patients sufficient immune-suppressive drugs to keep a donated organ without significantly increasing the risk of infection and cancer, said Dr. Laura L. Mulloy, Chief of the MCG Section of Nephrology, Hypertension and Transplantation Medicine.

"If we know a patient has naturally higher levels of HLA-G dimer they might need less immunosuppression which means less toxicity, less drug complications, and less cost," said Mulloy, a co-author of the study in the Journal of Immunology Research. Conversely patients with low levels might benefit from higher drug doses. "With this information, you can better customize and tailor-make your immunosuppressive cocktail."

High levels of HLA-G dimer also correlated with lower levels of inflammation, an immune response that can lead to rejection. The most successful transplants also had higher levels of HLA-G receptors, noted Horuzsko, the study's corresponding author.

While larger patient numbers are needed, the researchers' findings have continued to hold true in more than 150 kidney transplant patients at Georgia Regents Medical Center to date.

High HLA-G levels are known to correlate with successful pregnancy, HIV infection, and some cancers; low levels correlate with chronic miscarriages. Higher HLA-G levels also have been found in the blood of successful transplant patients, but the specific type was unknown, Horuzsko said.

In fact, HLA-G was thought to exist only as a single molecule until about five years ago, Horuzsko said. Functional assay technology has shown that if positioned just right, two molecules can connect and yield even more powerful tolerance.

Healthy individuals likely have very low levels of HLA-G dimer, which is part of the checks and balances of the immune response.

And, much as some fortunate people have naturally high levels of the good cholesterol, researchers now know that some transplant patients generate higher levels of this powerful HLA-G package, he said.

The tradeoff is the coupling makes HLA-G dimer more fragile so Horuzsko and several biotech companies are working to develop a more stable version that could one day supplement low levels.

Transplant patients are typically prescribed a standard immunosuppressive cocktail to avoid rejecting a new kidney and it's often unclear why some transplants fail and others succeed, Mulloy said. While necessary, the drugs increase the risk of other diseases and can even be toxic to a new kidney. A drug that worked more naturally and locally, "would be perfect," Mulloy said.

Horuzsko envisions HLA-G dimer eventually being delivered directly to dendritic cells, which make decisions about what to attack and ignore. He's already successfully delivered HLA-G carrying, degradable microparticles to mice with skin grafts to enhance tolerance. Ideally, patients would need such therapy only for a few weeks until dendritic cells learn to ignore the new organ. Drugs also are available to boost expression of HLA-G receptors.

Physicians already examine HLA, or human leukocyte antigen, when identifying the best organ donor. When a patient and donor have the same or similar antigens, which are markers for what the body identifies as self and foreign, it increases the chance of a successful transplant.


Story Source:

The above story is based on materials provided by Medical College of Georgia at Georgia Regents University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Maureen Ezeakile, Vera Portik-Dobos, Juan Wu, Daniel D. Horuzsko, Rajan Kapoor, Muralidharan Jagadeesan, Laura L. Mulloy, Anatolij Horuzsko. HLA-G Dimers in the Prolongation of Kidney Allograft Survival. Journal of Immunology Research, 2014; 2014: 1 DOI: 10.1155/2014/153981

Cite This Page:

Medical College of Georgia at Georgia Regents University. "Transplant success tied to naturally high levels of powerful immune molecule package." ScienceDaily. ScienceDaily, 28 April 2014. <www.sciencedaily.com/releases/2014/04/140428121351.htm>.
Medical College of Georgia at Georgia Regents University. (2014, April 28). Transplant success tied to naturally high levels of powerful immune molecule package. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2014/04/140428121351.htm
Medical College of Georgia at Georgia Regents University. "Transplant success tied to naturally high levels of powerful immune molecule package." ScienceDaily. www.sciencedaily.com/releases/2014/04/140428121351.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins